IBDEI23J ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,35180,2)
 ;;=^340504
 ;;^UTILITY(U,$J,358.3,35181,0)
 ;;=D50.9^^163^1793^26
 ;;^UTILITY(U,$J,358.3,35181,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35181,1,3,0)
 ;;=3^Iron Deficiency Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,35181,1,4,0)
 ;;=4^D50.9
 ;;^UTILITY(U,$J,358.3,35181,2)
 ;;=^5002283
 ;;^UTILITY(U,$J,358.3,35182,0)
 ;;=D64.81^^163^1793^2
 ;;^UTILITY(U,$J,358.3,35182,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35182,1,3,0)
 ;;=3^Anemia d/t Antineoplastic Chemotherapy
 ;;^UTILITY(U,$J,358.3,35182,1,4,0)
 ;;=4^D64.81
 ;;^UTILITY(U,$J,358.3,35182,2)
 ;;=^5002349
 ;;^UTILITY(U,$J,358.3,35183,0)
 ;;=D63.1^^163^1793^4
 ;;^UTILITY(U,$J,358.3,35183,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35183,1,3,0)
 ;;=3^Anemia in Chronic Kidney Disease
 ;;^UTILITY(U,$J,358.3,35183,1,4,0)
 ;;=4^D63.1
 ;;^UTILITY(U,$J,358.3,35183,2)
 ;;=^332908
 ;;^UTILITY(U,$J,358.3,35184,0)
 ;;=D62.^^163^1793^1
 ;;^UTILITY(U,$J,358.3,35184,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35184,1,3,0)
 ;;=3^Acute Blood Loss Anemia
 ;;^UTILITY(U,$J,358.3,35184,1,4,0)
 ;;=4^D62.
 ;;^UTILITY(U,$J,358.3,35184,2)
 ;;=^267986
 ;;^UTILITY(U,$J,358.3,35185,0)
 ;;=D51.9^^163^1793^32
 ;;^UTILITY(U,$J,358.3,35185,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35185,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,35185,1,4,0)
 ;;=4^D51.9
 ;;^UTILITY(U,$J,358.3,35185,2)
 ;;=^5002289
 ;;^UTILITY(U,$J,358.3,35186,0)
 ;;=D51.3^^163^1793^31
 ;;^UTILITY(U,$J,358.3,35186,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35186,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia,Dietary
 ;;^UTILITY(U,$J,358.3,35186,1,4,0)
 ;;=4^D51.3
 ;;^UTILITY(U,$J,358.3,35186,2)
 ;;=^5002287
 ;;^UTILITY(U,$J,358.3,35187,0)
 ;;=D51.0^^163^1793^28
 ;;^UTILITY(U,$J,358.3,35187,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35187,1,3,0)
 ;;=3^Pernicious Anemia
 ;;^UTILITY(U,$J,358.3,35187,1,4,0)
 ;;=4^D51.0
 ;;^UTILITY(U,$J,358.3,35187,2)
 ;;=^5002284
 ;;^UTILITY(U,$J,358.3,35188,0)
 ;;=D50.0^^163^1793^3
 ;;^UTILITY(U,$J,358.3,35188,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35188,1,3,0)
 ;;=3^Anemia d/t Blood Loss (Chronic)
 ;;^UTILITY(U,$J,358.3,35188,1,4,0)
 ;;=4^D50.0
 ;;^UTILITY(U,$J,358.3,35188,2)
 ;;=^267971
 ;;^UTILITY(U,$J,358.3,35189,0)
 ;;=E11.21^^163^1793^18
 ;;^UTILITY(U,$J,358.3,35189,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35189,1,3,0)
 ;;=3^DM Type 2 w/ Nephropathy
 ;;^UTILITY(U,$J,358.3,35189,1,4,0)
 ;;=4^E11.21
 ;;^UTILITY(U,$J,358.3,35189,2)
 ;;=^5002629
 ;;^UTILITY(U,$J,358.3,35190,0)
 ;;=E11.22^^163^1793^8
 ;;^UTILITY(U,$J,358.3,35190,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35190,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic CKD
 ;;^UTILITY(U,$J,358.3,35190,1,4,0)
 ;;=4^E11.22
 ;;^UTILITY(U,$J,358.3,35190,2)
 ;;=^5002630
 ;;^UTILITY(U,$J,358.3,35191,0)
 ;;=E11.29^^163^1793^19
 ;;^UTILITY(U,$J,358.3,35191,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35191,1,3,0)
 ;;=3^DM Type 2 w/ Other Diabetic Kidney Complication
 ;;^UTILITY(U,$J,358.3,35191,1,4,0)
 ;;=4^E11.29
 ;;^UTILITY(U,$J,358.3,35191,2)
 ;;=^5002631
 ;;^UTILITY(U,$J,358.3,35192,0)
 ;;=E11.311^^163^1793^20
 ;;^UTILITY(U,$J,358.3,35192,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35192,1,3,0)
 ;;=3^DM Type 2 w/ Unspec Diabetic Retinopathy w/ Macular edema
 ;;^UTILITY(U,$J,358.3,35192,1,4,0)
 ;;=4^E11.311
 ;;^UTILITY(U,$J,358.3,35192,2)
 ;;=^5002632
 ;;^UTILITY(U,$J,358.3,35193,0)
 ;;=E11.319^^163^1793^21
 ;;^UTILITY(U,$J,358.3,35193,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35193,1,3,0)
 ;;=3^DM Type 2 w/ Unspec Diabetic Retinopathy w/o Macular Edema
